Jefferies Group reiterated their hold rating on shares of Clorox (NYSE:CLX) in a research note published on Thursday, January 4th. Jefferies Group currently has a $148.00 target price on the stock.

Several other brokerages also recently commented on CLX. Zacks Investment Research downgraded shares of Clorox from a hold rating to a sell rating in a research note on Wednesday, October 4th. Wells Fargo & Co boosted their target price on shares of Clorox from $130.00 to $146.00 and gave the company a market perform rating in a research note on Thursday, January 4th. BMO Capital Markets reiterated a buy rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, October 5th. Bank of America upgraded shares of Clorox from an underperform rating to a neutral rating and set a $155.00 price target on the stock in a research report on Thursday, January 4th. Finally, Consumer Edge raised Clorox from a neutral rating to an outperform rating in a report on Friday, November 10th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. Clorox has a consensus rating of Hold and a consensus price target of $134.19.

How to Become a New Pot Stock Millionaire

Clorox (CLX) opened at $140.96 on Thursday. Clorox has a 52-week low of $119.57 and a 52-week high of $150.40. The company has a market cap of $18,391.80, a P/E ratio of 25.96, a PEG ratio of 3.73 and a beta of 0.42. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.41 by $0.05. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the previous year, the firm posted $1.36 earnings per share. Clorox’s revenue was up 4.0% compared to the same quarter last year. sell-side analysts forecast that Clorox will post 5.71 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is currently 61.88%.

In other news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Sun Life Financial INC increased its position in Clorox by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares during the period. Acrospire Investment Management LLC bought a new position in Clorox during the 2nd quarter worth $133,000. Phocas Financial Corp. bought a new position in shares of Clorox in the second quarter worth $167,000. Salem Investment Counselors Inc. increased its position in shares of Clorox by 2.5% in the second quarter. Salem Investment Counselors Inc. now owns 1,256 shares of the company’s stock worth $167,000 after purchasing an additional 31 shares during the period. Finally, Jacobi Capital Management LLC increased its position in shares of Clorox by 0.3% in the second quarter. Jacobi Capital Management LLC now owns 1,286 shares of the company’s stock worth $172,000 after purchasing an additional 4 shares during the period. Hedge funds and other institutional investors own 73.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first published by Marea Informative and is the sole property of of Marea Informative. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.mareainformativa.com/2018/01/30/cloroxs-clx-hold-rating-reiterated-at-jefferies-group-updated-updated-updated.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.